Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

MRES

Institute of Biomedical ... (PK) (MRES)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:MRES
DataOraFonteTitoloSimboloCompagnia
19/07/202315:18InvestorsHub NewsWireMRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory BoardUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
14/07/202314:52InvestorsHub NewsWireMRES: M2Bio Sciences Unveils an Exciting Line of Purple, White, and Green Teas from Kenya, Offering Extraordinary Health and Medicinal BenefitsUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
06/07/202315:38InvestorsHub NewsWireMRES: M2Bio Sciences Unveils Explainer Video Showcasing Groundbreaking NFTs and Altcoins for Drug Discovery, Revolutionizing Investment AccessUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
05/07/202316:04InvestorsHub NewsWireMRES: Institute of Biomedical Research Announces Application for Name Change and New Ticker Symbol in Anticipation of Future M&A Activities and Senior ListingUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
26/06/202314:45InvestorsHub NewsWireMRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAXUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
16/06/202314:30InvestorsHub NewsWireMRES: M2Bio Sciences Establishes Research Chair at The University of Pretoria for PhytomedicinesUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
14/06/202314:00InvestorsHub NewsWireMRES: M2Enviro Expands R&D Efforts to Explore Diverse Classes of Mycelium Composite Materials for CommercializationUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
07/06/202316:06InvestorsHub NewsWireMRES: Institute of Biomedical Research unveils artificial intelligence (AI) powered initiatives within its CBD product range, psilocybin research, and cardiometabolic health solutionsUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
06/04/202313:25InvestorsHub NewsWireM2Bio Appoints Ze-ev Krein as Chairman of the M2Bio Scientific Advisory BoardUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
16/06/201414:45MarketwiredThe Institute of Biomedical Research Corp.(MRES.PK) to Take Over Montenegro's National Testing & Research Institution "Center...USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
25/04/201420:45MarketwiredNeuro-Biotech Corp. (MRES.PK) Performs Reverse Split and Name Change to The Institute of Biomedical Research Corp.USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
10/02/201414:30MarketwiredNeuro-Biotech Corp. (MRES.PK) Performs Reverse Merger With the Institute of Biomedical ResearchUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
29/03/201317:54Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
29/06/201123:01Edgar (US Regulatory)Notification that Annual Report will be submitted late (NT 10-K)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
30/03/201123:24Edgar (US Regulatory)Current report filing (8-K)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
09/02/201119:45Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
16/08/201018:32Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
16/08/201016:45Edgar (US Regulatory)Amended Current report filing (8-K/A)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
27/07/201020:02MarketwiredNeuro-Biotech Corp. - Update to ShareholdersUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
02/07/201022:13Edgar (US Regulatory)Annual Report (10-K)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
27/07/200923:04Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
05/11/200819:04MarketwiredM45 Mining Resources Announces the Resignation of President and CEO, Appointment of New PresidentUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
16/10/200814:30MarketwiredM45 Mining Resources Announces Corporate Restructuring and Possible ResignationUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
18/09/200814:30MarketwiredM45 Mining Resources Inc. Has Entered Negotiations for the Purchase of Major Quebec ResortUSOTC:MRESInstitute of Biomedical Research Corporation New (PK)
20/08/200815:36Edgar (US Regulatory)M45 Mining Resources, Inc. - Quarterly Report (10-Q)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
14/08/200815:59Edgar (US Regulatory)M45 Mining Resources, Inc. - Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
30/06/200817:13Edgar (US Regulatory)M45 Mining Resources, Inc. - Annual Report (Small Business Issuers) (10KSB)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
30/06/200817:12Edgar (US Regulatory)M45 Mining Resources, Inc. - Amended Quarterly Report of Financial Condition (10QSB/A)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
20/02/200817:58Edgar (US Regulatory)M45 Mining Resources, Inc. - Quarterly Report of Financial Condition (10QSB)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
13/11/200719:17Edgar (US Regulatory)M45 Mining Resources, Inc. (Other) (NT 10-Q)USOTC:MRESInstitute of Biomedical Research Corporation New (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:MRES
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network